应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01093 石药集团
未开盘 02-25 16:08:35
9.990
-0.070
-0.70%
最高
10.220
最低
9.890
成交量
6,604万
今开
10.070
昨收
10.060
日振幅
3.28%
总市值
1,151亿
流通市值
1,151亿
总股本
115.22亿
成交额
6.62亿
换手率
0.57%
流通股本
115.22亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
海通国际:维持石药集团(01093)“优于大市”评级 目标价13.07港元
智通财经 · 02-25 14:07
海通国际:维持石药集团(01093)“优于大市”评级 目标价13.07港元
石药创新制药股份有限公司2026年第一次临时股东会通过重要关联交易议案
中访网数据 · 02-24 17:10
石药创新制药股份有限公司2026年第一次临时股东会通过重要关联交易议案
每日卖空追踪 | 石药集团 02月24日卖空量成交1011万股,卖空比例为9.89%
市场透视 · 02-24 16:30
每日卖空追踪 | 石药集团 02月24日卖空量成交1011万股,卖空比例为9.89%
石药集团02月24日主力净流出3405.2万元 散户资金买入
市场透视 · 02-24 16:15
石药集团02月24日主力净流出3405.2万元 散户资金买入
康宁杰瑞与石药集团合作开发的JSKN003完成首例患者给药
医药健闻 · 02-24 14:51
康宁杰瑞与石药集团合作开发的JSKN003完成首例患者给药
药企扎堆减肥药赛道,千亿美元赛道格局将生变
制药网 · 02-24 09:19
药企扎堆减肥药赛道,千亿美元赛道格局将生变
成为MNC还是CRO,中国新药需要选择吗?
盖德化工网 · 02-24 08:02
成为MNC还是CRO,中国新药需要选择吗?
38款新药有望进三甲
赛柏蓝 · 02-20
38款新药有望进三甲
每日卖空追踪 | 石药集团 02月20日卖空量成交851.4万股,卖空比例为15.41%
市场透视 · 02-20
每日卖空追踪 | 石药集团 02月20日卖空量成交851.4万股,卖空比例为15.41%
石药集团(01093):GLP -1/GIP受体双偏向性激动多肽长效注射液在美国获临床试验批准
智通财经 · 02-16
石药集团(01093):GLP -1/GIP受体双偏向性激动多肽长效注射液在美国获临床试验批准
石药集团(01093):罗哌卡因长效注射液(SYH9089注射液)在中国获临床试验批准
智通财经 · 02-16
石药集团(01093):罗哌卡因长效注射液(SYH9089注射液)在中国获临床试验批准
新“救星”,石药集团新型降脂药首仿来袭
北京药研汇 · 02-14
新“救星”,石药集团新型降脂药首仿来袭
6.63亿“抄底”,石药集团拿下知名药企控股权|重生局
北京药研汇 · 02-13
6.63亿“抄底”,石药集团拿下知名药企控股权|重生局
2026年中国生物科技授权交易将迎爆发式增长,有望创历史新高
新浪财经 · 02-13
2026年中国生物科技授权交易将迎爆发式增长,有望创历史新高
石药集团02月13日主力净流出2271.5万元 散户资金买入
市场透视 · 02-13
石药集团02月13日主力净流出2271.5万元 散户资金买入
石药巨石生物SYS6010启动Ⅲ期临床 适应症为经至少一线系统性治疗失败的局部晚期或转移性/复发食管鳞癌
新浪财经 · 02-12
石药巨石生物SYS6010启动Ⅲ期临床 适应症为经至少一线系统性治疗失败的局部晚期或转移性/复发食管鳞癌
阿斯利康中国去年收入66亿美元创新高 口服减肥药将进三期临床
澎湃新闻 · 02-11
阿斯利康中国去年收入66亿美元创新高 口服减肥药将进三期临床
每日卖空追踪 | 石药集团 02月11日卖空量成交948.4万股,卖空比例为9.47%
市场透视 · 02-11
每日卖空追踪 | 石药集团 02月11日卖空量成交948.4万股,卖空比例为9.47%
石药集团02月10日获主力大幅加仓1.9亿元
市场透视 · 02-10
石药集团02月10日获主力大幅加仓1.9亿元
创新药概念股普遍走高 石药集团涨超7%药明生物涨超5%
新浪港股 · 02-10
创新药概念股普遍走高 石药集团涨超7%药明生物涨超5%
加载更多
公司概况
公司名称:
石药集团
所属市场:
SEHK
上市日期:
--
主营业务:
石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品(包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片)、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":9.99,"timestamp":1772006915004,"preClose":10.06,"halted":0,"volume":66040333,"delay":0,"changeRate":-0.006958250497017921,"floatShares":11522000000,"shares":11522000000,"eps":0.42067939319815134,"marketStatus":"未开盘","change":-0.07,"latestTime":"02-25 16:08:35","open":10.07,"high":10.22,"low":9.89,"amount":662461388,"amplitude":0.032803,"askPrice":9.99,"askSize":720000,"bidPrice":9.98,"bidSize":406000,"shortable":3,"etf":0,"ttmEps":0.4041667931684353,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772069400000},"marketStatusCode":0,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":10.06,"dividendRate":0.024004,"openAndCloseTimeList":[[1771983000000,1771992000000],[1771995600000,1772006400000]],"volumeRatio":1.005351794573063,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.5224,"impliedVolPercentile":0.4472},"requestUrl":"/m/hq/s/01093","defaultTab":"news","newsList":[{"id":"2614677729","title":"海通国际:维持石药集团(01093)“优于大市”评级 目标价13.07港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614677729","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614677729?lang=zh_cn&edition=full","pubTime":"2026-02-25 14:07","pubTimestamp":1771999659,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,海通国际发布研报称,石药集团的主营业务收入、利润已经触底,2026年有望回到上升周期,2027年开始受益于肿瘤和代谢创新产品放量,成药收入有望提速。基于WACC 7.9%,永续增长率2.5%(均不变),对应目标价13.07港元,并维持“优于大市”评级。海通国际主要观点如下:研发能力多次获得认可,该行看好常态化里程碑收入夯实公司基本面近两年来石药集团实现7笔对外合作交易,涉及首付款总额17.1亿美元,潜在里程碑总额超300亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01093"],"gpt_icon":0},{"id":"2614744176","title":"石药创新制药股份有限公司2026年第一次临时股东会通过重要关联交易议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2614744176","media":"中访网数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614744176?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:10","pubTimestamp":1771924200,"startTime":"0","endTime":"0","summary":"中访网数据石药创新制药股份有限公司于2026年2月24日以现场结合网络投票方式成功召开了2026年第一次临时股东会。本次会议审议并表决通过了《关于控股子公司及关联方共同与阿斯利康签署战略合作与授权协议暨关联交易的议案》。该议案涉及关联交易,关联股东已依法回避表决,并对中小投资者的投票情况进行了单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224171042a4c25c0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224171042a4c25c0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","IE00BZ08YR35.GBP","LU1226287529.USD","LU1226288170.HKD","LU1226287875.USD","LU1951186391.HKD","LU1152091754.HKD","LU1960683339.HKD","LU1152091168.USD","LU2039709279.SGD","LU1226287792.SGD","IE0008368742.USD","LU0140636845.USD","LU0314109678.HKD","IE00BZ08YT58.USD","LU1813983027.USD","01477","LU0067412154.USD","LU0072913022.USD","LU0326950275.SGD","BK1515","LU1328277881.USD","SG9999004220.SGD","BK1521","BK1191","LU0501845795.SGD","IE00B5MMRT66.SGD","LU1226288253.USD","LU1993786604.SGD","LU0880133367.SGD","HK0000165453.HKD","IE00BZ08YS42.EUR","IE0008369823.USD","01093","BK1574","LU0315179316.USD","LU1008478684.HKD","IE00B031HY20.USD","LU1807302812.USD"],"gpt_icon":0},{"id":"2614441207","title":"每日卖空追踪 | 石药集团 02月24日卖空量成交1011万股,卖空比例为9.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614441207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614441207?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:30","pubTimestamp":1771921817,"startTime":"0","endTime":"0","summary":"石药集团北京时间02月24日,跌5.18%,卖空量成交1011万股,较上一交易日减少62.15%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163207a4c2332c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163207a4c2332c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","IE00BZ08YT58.USD","LU1807302812.USD","IE00B543WZ88.USD","LU1951186391.HKD","LU1813983027.USD","01093","BK1521","LU1226287875.USD","IE0008368742.USD","LU0315179316.USD","LU1226288253.USD","LU1328277881.USD","BK1191","IE0008369823.USD","LU0880133367.SGD","IE00B5MMRT66.SGD","LU0501845795.SGD","LU0072913022.USD","LU1226288170.HKD","LU0326950275.SGD","SG9999004220.SGD","LU2039709279.SGD","IE00BZ08YR35.GBP","LU1152091168.USD","LU1008478684.HKD","HK0000165453.HKD","IE00B031HY20.USD","LU0140636845.USD","LU0314109678.HKD","LU1226287529.USD","LU1960683339.HKD","LU1152091754.HKD","LU1993786604.SGD","LU1226287792.SGD","LU0067412154.USD","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"2614744178","title":"石药集团02月24日主力净流出3405.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614744178","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614744178?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:15","pubTimestamp":1771920935,"startTime":"0","endTime":"0","summary":"02月24日, 石药集团股价跌5.18%,报收10.06元,成交金额10.4亿元,换手率0.89%,振幅5.66%,量比1.75。石药集团今日主力资金净流出3405.2万元,上一交易日主力净流入7909.5万元。该股近5个交易日下跌4.73%,主力资金累计净流入3094.5万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流入6.4亿元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161756a7190991&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161756a7190991&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","IE00BZ08YR35.GBP","LU1226287529.USD","LU1226288170.HKD","LU1226287875.USD","LU1951186391.HKD","LU1152091754.HKD","LU1960683339.HKD","LU1152091168.USD","LU2039709279.SGD","LU1226287792.SGD","IE0008368742.USD","LU0140636845.USD","LU0314109678.HKD","IE00BZ08YT58.USD","LU1813983027.USD","LU0067412154.USD","LU0072913022.USD","LU0326950275.SGD","BK1515","LU1328277881.USD","SG9999004220.SGD","BK1521","BK1191","LU0501845795.SGD","IE00B5MMRT66.SGD","LU1226288253.USD","LU1993786604.SGD","LU0880133367.SGD","HK0000165453.HKD","IE00BZ08YS42.EUR","IE0008369823.USD","01093","LU0315179316.USD","LU1008478684.HKD","IE00B031HY20.USD","LU1807302812.USD"],"gpt_icon":0},{"id":"2614744172","title":"康宁杰瑞与石药集团合作开发的JSKN003完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2614744172","media":"医药健闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614744172?lang=zh_cn&edition=full","pubTime":"2026-02-24 14:51","pubTimestamp":1771915871,"startTime":"0","endTime":"0","summary":"(医药健闻 2026年02月24日讯)康宁杰瑞生物制药宣布,公司自主研发、与石药集团全资附属公司上海津曼特生物科技有限公司合作开发的HER2双特异性抗体偶联药物(ADC)JSKN003治疗HER2阳性晚期结直肠癌的Ⅲ期临床研究(研究编号:JSKN003-005)已完成首例患者给药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224145117a4c1caed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224145117a4c1caed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0880133367.SGD","IE00BZ08YR35.GBP","LU1226287875.USD","LU1993786604.SGD","LU1226288170.HKD","LU1960683339.HKD","LU0067412154.USD","LU1226287529.USD","IE00B031HY20.USD","LU1226287792.SGD","01093","IE00B543WZ88.USD","LU1008478684.HKD","BK1191","LU0501845795.SGD","SG9999004220.SGD","HK0000165453.HKD","BK1515","LU2039709279.SGD","IE0008368742.USD","BK1521","LU1328277881.USD","LU1807302812.USD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","LU0314109678.HKD","IE0008369823.USD","LU1152091168.USD","LU0072913022.USD","LU0326950275.SGD","LU1813983027.USD","IE00B5MMRT66.SGD","LU1226288253.USD","LU0140636845.USD","LU0315179316.USD","LU1951186391.HKD","LU1152091754.HKD"],"gpt_icon":0},{"id":"2613275783","title":"药企扎堆减肥药赛道,千亿美元赛道格局将生变","url":"https://stock-news.laohu8.com/highlight/detail?id=2613275783","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613275783?lang=zh_cn&edition=full","pubTime":"2026-02-24 09:19","pubTimestamp":1771895983,"startTime":"0","endTime":"0","summary":"据相关预测,到 2030 年,全球减肥药市场价值有望突破 1500 亿美元。除了礼来,2026年以来还有大批医药企业在减肥药方面加速布局。如1月30日,石药集团公告称,已与阿斯利康签署战略研发合作与授权协议。本次合作,潜在总金额高达185亿美元。未来,行业竞争预计会愈演愈烈,企业需构建差异化技术壁垒、强化商业化能力、拓展适应症边界,才能在千亿美元赛道中脱颖而出。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224092341a71795ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224092341a71795ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","NVOX","LU1093756168.USD","NVOH","NVO","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LLY","BK4585","BK4007","BK4599","LU1093756325.SGD","BK4532","BK4588","01093"],"gpt_icon":1},{"id":"2613768863","title":"成为MNC还是CRO,中国新药需要选择吗?","url":"https://stock-news.laohu8.com/highlight/detail?id=2613768863","media":"盖德化工网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613768863?lang=zh_cn&edition=full","pubTime":"2026-02-24 08:02","pubTimestamp":1771891327,"startTime":"0","endTime":"0","summary":"Guide View成为MNC还是CRO,这是2月份在新药领域引发争议的一个话题。Guide View面对上述担忧,更多的人士认为,随着多元合作模式的探索落地,国产新药自主全球化提速,成为MNC还是CRO,不是中国新药需要做的一项选择题。结语Guide View种种迹象说明,成为MNC还是CRO不会是中国新药的一道选择题,中国新药具备广阔的兼容性,技术与效率驱动时代,可以多条腿走路探索,多数boitech的务实需求是先赚钱后谈梦想,少数Biopharma却会先成为种子,等待长成参天大树的那天。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224080919a717553d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224080919a717553d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","HK0000165453.HKD","LU2097828714.EUR","LU1969619763.USD","LU2488822045.USD","LU2097828631.EUR","LU2097828805.USD","LU2328871848.SGD","LU2242644610.SGD","LU2097828557.USD","LU0502904849.HKD","LU2097828474.EUR","01093","LU0455707207.USD","01801","BK1589","02196"],"gpt_icon":0},{"id":"2613872219","title":"38款新药有望进三甲","url":"https://stock-news.laohu8.com/highlight/detail?id=2613872219","media":"赛柏蓝","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613872219?lang=zh_cn&edition=full","pubTime":"2026-02-20 18:21","pubTimestamp":1771582875,"startTime":"0","endTime":"0","summary":"编者按:本文来自米内网,作者苍穹;赛柏蓝授权转载,编辑相宜近日,广安公共资源交易网发布公告,岳池县人民医院将引进38款新药以满足临床用药需求,“中化生”领域均有涉及。38款拟进院新药包含5款医保甲类药、31款医保乙类药和2款非医保药;按治疗大类统计,消化系统及代谢药、血液和造血系统药物各以6个产品在数量上领跑;从药品类型上看,化药、生物药、中成药各占31个、5个和2个席位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220182728a4b62993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220182728a4b62993&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226288170.HKD","IE0008368742.USD","LU0067412154.USD","LU1226288253.USD","LU0501845795.SGD","LU1152091168.USD","LU0072913022.USD","LU1993786604.SGD","IE00B543WZ88.USD","01093","IE00B5MMRT66.SGD","BK1521","LU1328277881.USD","IE00BZ08YR35.GBP","LU1226287792.SGD","LU0315179316.USD","BK1515","LU1807302812.USD","LU0880133367.SGD","SG9999004220.SGD","BK1191","IE00BZ08YT58.USD","LU1960683339.HKD","IE00BZ08YS42.EUR","LU0140636845.USD","LU1226287875.USD","IE00B031HY20.USD","LU1226287529.USD","LU1152091754.HKD","LU2039709279.SGD","HK0000165453.HKD","LU0326950275.SGD","IE0008369823.USD","LU1813983027.USD","LU1951186391.HKD","LU1008478684.HKD","LU0314109678.HKD"],"gpt_icon":0},{"id":"2613219841","title":"每日卖空追踪 | 石药集团 02月20日卖空量成交851.4万股,卖空比例为15.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613219841","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613219841?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:30","pubTimestamp":1771576218,"startTime":"0","endTime":"0","summary":"石药集团北京时间02月20日,涨2.63%,卖空量成交851.4万股,较上一交易日增加72.14%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163214a4b5e72d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163214a4b5e72d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0314109678.HKD","LU1328277881.USD","LU0067412154.USD","LU1993786604.SGD","LU1152091168.USD","LU1226288253.USD","IE0008368742.USD","LU1226287792.SGD","IE0008369823.USD","HK0000165453.HKD","IE00B5MMRT66.SGD","LU1152091754.HKD","LU0140636845.USD","LU0880133367.SGD","BK1191","LU1960683339.HKD","BK1515","IE00B543WZ88.USD","LU0326950275.SGD","LU1226287529.USD","IE00BZ08YS42.EUR","LU1008478684.HKD","SG9999004220.SGD","LU0501845795.SGD","IE00BZ08YR35.GBP","LU1226288170.HKD","LU1813983027.USD","LU1807302812.USD","BK1521","LU2039709279.SGD","01093","IE00BZ08YT58.USD","LU1951186391.HKD","LU0315179316.USD","LU0072913022.USD","LU1226287875.USD","IE00B031HY20.USD"],"gpt_icon":0},{"id":"2611055921","title":"石药集团(01093):GLP -1/GIP受体双偏向性激动多肽长效注射液在美国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2611055921","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611055921?lang=zh_cn&edition=full","pubTime":"2026-02-16 13:37","pubTimestamp":1771220261,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团 发布公告,本集团开发的GLP-1/GIP受体双偏向性激动多肽长效注射液已获得美国食品药品监督管理局批准,可在美国开展临床试验。SYH2082有望成为临床开发阶段具领先潜力的长效GLP-1/GIP受体双重偏向性激动剂,每月给药一次。依托本集团的长效制剂技术平台,SYH2082实现月度给药,提高患者依从性与用药便捷性。在毒理学研究中,SYH2082的耐受性良好,未观察到显著不良反应。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","IE0008369823.USD","LU0072913022.USD","LU0140636845.USD","LU1226287529.USD","LU1226287792.SGD","LU1993786604.SGD","IE0008368742.USD","LU1951186391.HKD","LU1008478684.HKD","SG9999004220.SGD","IE00B5MMRT66.SGD","LU1226288170.HKD","LU1813983027.USD","BK1521","IE00BZ08YS42.EUR","LU0326950275.SGD","LU1152091754.HKD","LU0315179316.USD","BK4144","01093","GLP","LU1152091168.USD","LU1226288253.USD","IE00BZ08YR35.GBP","HK0000165453.HKD","LU2039709279.SGD","IE00B031HY20.USD","IE00B543WZ88.USD","LU1226287875.USD","IE00BZ08YT58.USD","LU1807302812.USD","BK4590","LU1328277881.USD","BK1191","LU0067412154.USD","LU0880133367.SGD","LU0501845795.SGD","LU0314109678.HKD","LU1960683339.HKD"],"gpt_icon":0},{"id":"2611105566","title":"石药集团(01093):罗哌卡因长效注射液(SYH9089注射液)在中国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2611105566","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611105566?lang=zh_cn&edition=full","pubTime":"2026-02-16 13:35","pubTimestamp":1771220120,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团 发布公告,集团开发的罗哌卡因长效注射液(该产品)已获得中华人民共和国国家药品监督管理局批准,可在中国开展临床试验。依托集团的长效药物递送技术平台,该产品可将单次给药镇痛持续时间延长至一周,有望成为中国首款镇痛持续时间达到一周的超长效镇痛产品。本次获批的临床适应症为术后镇痛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405697.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000165453.HKD","LU1226287529.USD","BK1515","LU1993786604.SGD","LU1152091754.HKD","LU0501845795.SGD","LU0067412154.USD","LU0880133367.SGD","LU0314109678.HKD","LU1226288170.HKD","LU0072913022.USD","LU1226287792.SGD","IE0008369823.USD","IE00BZ08YR35.GBP","IE00B543WZ88.USD","LU0140636845.USD","LU1152091168.USD","LU1807302812.USD","LU1226287875.USD","LU1226288253.USD","BK1191","IE0008368742.USD","IE00B031HY20.USD","LU1008478684.HKD","01093","SG9999004220.SGD","IE00BZ08YS42.EUR","LU1951186391.HKD","IE00B5MMRT66.SGD","LU1813983027.USD","BK1521","IE00BZ08YT58.USD","LU0326950275.SGD","LU1960683339.HKD","LU2039709279.SGD","LU0315179316.USD","LU1328277881.USD"],"gpt_icon":0},{"id":"2611480801","title":"新“救星”,石药集团新型降脂药首仿来袭","url":"https://stock-news.laohu8.com/highlight/detail?id=2611480801","media":"北京药研汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611480801?lang=zh_cn&edition=full","pubTime":"2026-02-14 08:01","pubTimestamp":1771027281,"startTime":"0","endTime":"0","summary":"高血脂症是导致动脉粥样硬化、冠心病等心血管疾病的罪魁祸首,同时也是糖尿病、肾衰竭等严重疾病的潜在风险。国内仿制情况,贝派度酸片原研药及仿制药均未尚未在国内上市。截至目前为止,国内已有甘李药业山东有限公司、江西施美药业、合肥立方制药、石药集团欧意药业4家药企申报的贝派度酸片临床申请均获受理,首仿之争已拉开帷幕。高血脂,作为心血管疾病及相关死亡的“头号元凶”,其危害不容小觑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021408204097a6261d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021408204097a6261d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YR35.GBP","LU1152091168.USD","LU1951186391.HKD","LU0501845795.SGD","LU1813983027.USD","LU0315179316.USD","LU2039709279.SGD","LU1328277881.USD","LU0880133367.SGD","LU0326950275.SGD","IE00BZ08YS42.EUR","LU1226287875.USD","LU1960683339.HKD","LU1008478684.HKD","IE00BZ08YT58.USD","BK1521","IE00B031HY20.USD","LU1807302812.USD","LU1993786604.SGD","LU0067412154.USD","IE0008369823.USD","LU1226287529.USD","LU0072913022.USD","BK1191","LU1226288170.HKD","BK1515","LU1226287792.SGD","SG9999004220.SGD","HK0000165453.HKD","IE0008368742.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0314109678.HKD","LU1152091754.HKD","LU1226288253.USD","LU0140636845.USD","01093"],"gpt_icon":0},{"id":"2611169820","title":"6.63亿“抄底”,石药集团拿下知名药企控股权|重生局","url":"https://stock-news.laohu8.com/highlight/detail?id=2611169820","media":"北京药研汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611169820?lang=zh_cn&edition=full","pubTime":"2026-02-13 18:13","pubTimestamp":1770977633,"startTime":"0","endTime":"0","summary":"近日,此前一度面临退市风险的湖南景峰医药正式官宣破产重整,其重整计划取得重要突破。根据当日公布的重整计划草案,石药控股集团有限公司作为牵头投资人,联合其余18家重整参与方,将共同受让景峰医药转增的879,774,351股股份,总投资额约20.61亿元。石药集团一出手就是6.63亿,直接拿下控股权。根据重整计划草案,仅石药集团受让股份的对价就达6.63亿元,后续可能还需持续投入资源,帮助该公司恢复经营活力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021319574595410d29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021319574595410d29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226287529.USD","LU1993786604.SGD","LU0501845795.SGD","01093","LU0314109678.HKD","IE00BZ08YS42.EUR","LU1328277881.USD","LU1226288170.HKD","LU1152091168.USD","IE0008368742.USD","LU1226287875.USD","LU0140636845.USD","IE00B5MMRT66.SGD","LU1960683339.HKD","LU1226288253.USD","IE00B543WZ88.USD","LU1226287792.SGD","LU0880133367.SGD","LU1008478684.HKD","LU1951186391.HKD","BK1521","IE00BZ08YT58.USD","BK1191","BK1515","LU0326950275.SGD","HK0000165453.HKD","LU0067412154.USD","IE00BZ08YR35.GBP","IE0008369823.USD","SG9999004220.SGD","LU2039709279.SGD","LU0072913022.USD","IE00B031HY20.USD","LU1152091754.HKD","LU0315179316.USD","LU1807302812.USD","LU1813983027.USD"],"gpt_icon":0},{"id":"2611165746","title":"2026年中国生物科技授权交易将迎爆发式增长,有望创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2611165746","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611165746?lang=zh_cn&edition=full","pubTime":"2026-02-13 17:05","pubTimestamp":1770973500,"startTime":"0","endTime":"0","summary":"全球制药企业在专利到期前纷纷削减成本,正加大力度寻找中国研发的创新候选药物,行业分析师预计,今年相关授权交易规模将飙升至历史新高。2026 年至今已宣布38 笔对外授权交易;2025 年全年为186 笔。行业咨询机构 Vision Lifesciences 在 2026 年生物科技授权展望中称,中国在抗体药物偶联物领域全球领先,相关授权交易占全球近90%。首付款大幅上涨随着交易规模扩大,全球药企获取中国药物开发权所需支付的首付款也大幅飙升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213182820a6f7567b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213182820a6f7567b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01093","06938"],"gpt_icon":0},{"id":"2611169826","title":"石药集团02月13日主力净流出2271.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2611169826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611169826?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:16","pubTimestamp":1770970560,"startTime":"0","endTime":"0","summary":"02月13日, 石药集团股价跌0.30%,报收10.11元,成交金额4.6亿元,换手率0.39%,振幅2.07%,量比0.47。石药集团今日主力资金净流出2271.5万元,上一交易日主力净流入3004.4万元。该股近5个交易日上涨5.69%,主力资金累计净流入2.6亿元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入6.6亿元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213162207a6f6d6f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213162207a6f6d6f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1008478684.HKD","LU0501845795.SGD","LU1807302812.USD","HK0000165453.HKD","BK1191","LU1813983027.USD","IE0008369823.USD","LU1951186391.HKD","LU1226287792.SGD","LU0880133367.SGD","BK1521","LU0072913022.USD","LU0314109678.HKD","LU0140636845.USD","LU0315179316.USD","IE0008368742.USD","LU2039709279.SGD","LU1328277881.USD","IE00B5MMRT66.SGD","LU1152091754.HKD","01093","LU1226287875.USD","IE00B031HY20.USD","LU1993786604.SGD","IE00BZ08YR35.GBP","LU0326950275.SGD","LU1960683339.HKD","IE00B543WZ88.USD","LU1226287529.USD","SG9999004220.SGD","LU1226288253.USD","BK1515","IE00BZ08YT58.USD","LU1152091168.USD","IE00BZ08YS42.EUR","LU1226288170.HKD","LU0067412154.USD"],"gpt_icon":0},{"id":"2611906562","title":"石药巨石生物SYS6010启动Ⅲ期临床 适应症为经至少一线系统性治疗失败的局部晚期或转移性/复发食管鳞癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2611906562","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611906562?lang=zh_cn&edition=full","pubTime":"2026-02-12 18:03","pubTimestamp":1770890580,"startTime":"0","endTime":"0","summary":"本次试验主要目的为评价SYS6010对比研究者选择的单药化疗在经至少一线系统性治疗失败的局部晚期或转移性/复发食管鳞癌参与者中的有效性;次要目的为进一步评价有效性、评价安全性、评价PK特征、评价免疫原性特征及评价EGFR蛋白表达水平与疗效相关性。SYS6010为生物制品,适应症为经至少一线系统性治疗失败的局部晚期或转移性/复发食管鳞癌。食管鳞癌是食管癌主要亚型,晚期患者预后差,一线治疗失败后缺乏有效疗法,严重威胁患者生存。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212185311a6f3170b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212185311a6f3170b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","IE0008369823.USD","LU0072913022.USD","LU0140636845.USD","LU1226287529.USD","LU1226287792.SGD","LU1993786604.SGD","IE0008368742.USD","LU1951186391.HKD","LU1008478684.HKD","SG9999004220.SGD","IE00B5MMRT66.SGD","LU1226288170.HKD","LU1813983027.USD","BK1521","IE00BZ08YS42.EUR","LU0326950275.SGD","LU1152091754.HKD","LU0315179316.USD","01093","LU1152091168.USD","LU1226288253.USD","IE00BZ08YR35.GBP","HK0000165453.HKD","LU2039709279.SGD","IE00B031HY20.USD","IE00B543WZ88.USD","LU1226287875.USD","IE00BZ08YT58.USD","LU1807302812.USD","LU1328277881.USD","BK1191","LU0067412154.USD","LU0880133367.SGD","LU0501845795.SGD","LU0314109678.HKD","LU1960683339.HKD"],"gpt_icon":0},{"id":"2610997527","title":"阿斯利康中国去年收入66亿美元创新高 口服减肥药将进三期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2610997527","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610997527?lang=zh_cn&edition=full","pubTime":"2026-02-11 22:06","pubTimestamp":1770818785,"startTime":"0","endTime":"0","summary":"当地时间2月10日,阿斯利康发布2025年业绩,全年总营收587.39亿美元,同比增长8%,其中产品收入586.4亿美元,同比增长10%。从地区分布来看,2025年美国市场收入254.5亿美元,同比增长10%,新兴市场收入153.03亿美元,同比增长14%,其中阿斯利康中国2025年总营收为66.54亿美元,创历史新高,同比增长4%,占据阿斯利康全球市场份额的11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211221813a6ef5edf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211221813a6ef5edf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226287529.USD","LU1993786604.SGD","LU1152091754.HKD","BK1191","HK0000165453.HKD","LU0140636845.USD","01093","SG9999004220.SGD","LU1807302812.USD","LU0315179316.USD","IE00BZ08YR35.GBP","BK1515","LU0314109678.HKD","LU1226288170.HKD","LU1226288253.USD","LU1813983027.USD","LU1152091168.USD","IE00BZ08YS42.EUR","LU1008478684.HKD","LU1328277881.USD","LU0072913022.USD","IE00BZ08YT58.USD","LU1960683339.HKD","IE00B031HY20.USD","IE0008369823.USD","LU1226287792.SGD","LU0326950275.SGD","LU0880133367.SGD","BK1521","LU1951186391.HKD","IE0008368742.USD","LU0501845795.SGD","LU2039709279.SGD","IE00B543WZ88.USD","LU0067412154.USD","LU1226287875.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2610975659","title":"每日卖空追踪 | 石药集团 02月11日卖空量成交948.4万股,卖空比例为9.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610975659","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610975659?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:30","pubTimestamp":1770798619,"startTime":"0","endTime":"0","summary":"石药集团北京时间02月11日,涨1.55%,卖空量成交948.4万股,较上一交易日减少63.45%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163210a6ee1bc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163210a6ee1bc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0314109678.HKD","LU0140636845.USD","IE00B543WZ88.USD","LU1226287875.USD","LU1226288170.HKD","LU0501845795.SGD","LU1152091168.USD","LU1960683339.HKD","IE0008368742.USD","LU1328277881.USD","LU1813983027.USD","IE00BZ08YT58.USD","IE00B031HY20.USD","LU0880133367.SGD","LU1152091754.HKD","LU0315179316.USD","LU0326950275.SGD","01093","IE00BZ08YR35.GBP","LU1993786604.SGD","LU0067412154.USD","LU1226287529.USD","IE00B5MMRT66.SGD","BK1191","LU1226288253.USD","LU1226287792.SGD","SG9999004220.SGD","IE0008369823.USD","LU1951186391.HKD","BK1521","LU1807302812.USD","LU1008478684.HKD","LU2039709279.SGD","IE00BZ08YS42.EUR","HK0000165453.HKD","BK1515","LU0072913022.USD"],"gpt_icon":0},{"id":"2610271216","title":"石药集团02月10日获主力大幅加仓1.9亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610271216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610271216?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:15","pubTimestamp":1770711347,"startTime":"0","endTime":"0","summary":"02月10日, 石药集团股价涨5.52%,报收10.32元,成交金额15.5亿元,换手率1.30%,振幅8.69%,量比1.35。石药集团今日主力资金净流入1.9亿元,连续3日净流入,上一交易日主力净流入7663.0万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为55.00%,平均涨幅为3.99%。该股近5个交易日上涨3.34%,主力资金累计净流入2.1亿元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入7.6亿元,其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210161953a6e99ab3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210161953a6e99ab3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1993786604.SGD","BK1191","LU0067412154.USD","LU1226287792.SGD","LU1960683339.HKD","01093","LU0072913022.USD","IE00BZ08YR35.GBP","IE0008368742.USD","LU0880133367.SGD","LU1328277881.USD","IE00B031HY20.USD","LU0326950275.SGD","LU1807302812.USD","LU1226288170.HKD","SG9999004220.SGD","IE0008369823.USD","LU1813983027.USD","LU0140636845.USD","LU0314109678.HKD","BK1521","LU0315179316.USD","LU1226287529.USD","IE00BZ08YS42.EUR","LU1951186391.HKD","IE00BZ08YT58.USD","BK1515","LU1152091168.USD","LU0501845795.SGD","LU1226288253.USD","LU1152091754.HKD","LU2039709279.SGD","LU1008478684.HKD","HK0000165453.HKD","IE00B543WZ88.USD","LU1226287875.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2610943736","title":"创新药概念股普遍走高 石药集团涨超7%药明生物涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610943736","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610943736?lang=zh_cn&edition=full","pubTime":"2026-02-10 11:34","pubTimestamp":1770694440,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 创新药概念股午前普遍走高,截至发稿,石药集团(01093)上涨7.16%,报10.48港元;药明生物(02269)上涨5.54%,报40.36港元;康诺亚-B(02162)上涨5.45%,报60.95港元;信达生物(01801)上涨5.15%,报89.8港元;再鼎医药(09688)上涨4.9%,报14.76港元。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-02-10/doc-inhmiaep8549540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","LU0327786744.USD","BK1515","LU0359202008.SGD","LU0516423174.USD","LU0708995583.HKD","LU1152091168.USD","LU1880383366.USD","IE00B543WZ88.USD","LU0052750758.USD","LU1226287529.USD","LU1993786604.SGD","BK1610","LU0516423091.SGD","LU1226287875.USD","02269","LU1688375341.USD","IE00B031HY20.USD","LU1794554557.SGD","LU0501845795.SGD","IE0008368742.USD","LU0359201612.USD","LU1813983027.USD","159992","BK1574","LU0326950275.SGD","01093","IE00BZ08YT58.USD","LU0320764599.SGD","LU1152091754.HKD","LU1242518857.USD","LU1807302812.USD","HK0000165453.HKD","LU0348825331.USD","LU0880133367.SGD","BK1141","LU0979878070.USD","LU1242518931.SGD","BK1191","LU0456827905.SGD","LU2039709279.SGD","BK1521","SG9999002562.SGD","BK1576","LU0456846285.SGD","LU0417516902.SGD","06978","LU3063872942.SGD","LU0588546209.SGD","LU0039217434.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":-0.0254},{"period":"1month","weight":0.0406},{"period":"3month","weight":0.2425},{"period":"6month","weight":0.0073},{"period":"1year","weight":1.0425},{"period":"ytd","weight":0.1851}],"compareEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0},{"period":"3month","weight":0.0316},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.162},{"period":"ytd","weight":0.0443}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品(包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片)、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.53125,"avgChangeRate":0.009625},{"month":2,"riseRate":0.75,"avgChangeRate":0.09498},{"month":3,"riseRate":0.483871,"avgChangeRate":0.020489},{"month":4,"riseRate":0.612903,"avgChangeRate":0.062074},{"month":5,"riseRate":0.612903,"avgChangeRate":0.047434},{"month":6,"riseRate":0.322581,"avgChangeRate":0.003636},{"month":7,"riseRate":0.375,"avgChangeRate":0.009082},{"month":8,"riseRate":0.4375,"avgChangeRate":0.010009},{"month":9,"riseRate":0.5,"avgChangeRate":0.000153},{"month":10,"riseRate":0.5625,"avgChangeRate":0.010484},{"month":11,"riseRate":0.46875,"avgChangeRate":0.00638},{"month":12,"riseRate":0.5,"avgChangeRate":-0.013271}],"exchange":"SEHK","name":"石药集团","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石药集团,01093,石药集团股票,石药集团股票老虎,石药集团股票老虎国际,石药集团行情,石药集团股票行情,石药集团股价,石药集团股市,石药集团股票价格,石药集团股票交易,石药集团股票购买,石药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}